Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 2
1985 4
1986 12
1987 5
1988 21
1989 5
1990 5
1991 12
1992 11
1993 23
1994 32
1995 7
1996 14
1997 13
1998 12
1999 11
2000 11
2001 15
2002 9
2003 18
2004 15
2005 15
2006 16
2007 14
2008 23
2009 22
2010 13
2011 16
2012 10
2013 14
2014 18
2015 23
2016 14
2017 19
2018 16
2019 23
2020 26
2021 31
2022 34
2023 28
2024 53
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

644 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, Testani JM, Harrington AH, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ; TRANSFORM-HF Investigators. Mentz RJ, et al. JAMA. 2023 Jan 17;329(3):214-223. doi: 10.1001/jama.2022.23924. JAMA. 2023. PMID: 36648467 Free PMC article. Clinical Trial.
IMPORTANCE: Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential benefit for torsemide. OBJECTIVE: To determine whether torsemide results in decreased mortality compared with furosemide among pa …
IMPORTANCE: Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential ben …
Torsemide.
[No authors listed] [No authors listed] 2024 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000180 Free Books & Documents. Review.
Because little information is available on the use of torsemide during breastfeeding and because intense diuresis might decrease lactation, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Low doses of torsemide may not suppr …
Because little information is available on the use of torsemide during breastfeeding and because intense diuresis might decrease lact …
Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
Abraham B, Megaly M, Sous M, Fransawyalkomos M, Saad M, Fraser R, Topf J, Goldsmith S, Simegn M, Bart B, Azzo Z, Mesiha N, Sharma R. Abraham B, et al. Am J Cardiol. 2020 Jan 1;125(1):92-99. doi: 10.1016/j.amjcard.2019.09.039. Epub 2019 Oct 10. Am J Cardiol. 2020. PMID: 31699358 Review.
Although torsemide's oral bioavailability and half-life theoretically render it a more efficient diuretic than furosemide, the clinical outcomes of torsemide compared with furosemide remain unclear. We performed a systematic review and meta-analysis, including all p …
Although torsemide's oral bioavailability and half-life theoretically render it a more efficient diuretic than furosemide, the clinic …
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Greene SJ, Velazquez EJ, Anstrom KJ, Clare RM, DeWald TA, Psotka MA, Ambrosy AP, Stevens GR, Rommel JJ, Alexy T, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Eisenstein EL, Mentz RJ; TRANSFORM-HF Investigators. Greene SJ, et al. Circulation. 2023 Jul 11;148(2):124-134. doi: 10.1161/CIRCULATIONAHA.123.064842. Epub 2023 May 22. Circulation. 2023. PMID: 37212600 Free PMC article. Clinical Trial.
As prespecified secondary end points, the TRANSFORM-HF trial (Torsemide Comparison With Furosemide for Management of Heart Failure) compared the effect of torsemide versus furosemide on patient-reported outcomes among patients with HF. ...The effects of torsemide …
As prespecified secondary end points, the TRANSFORM-HF trial (Torsemide Comparison With Furosemide for Management of Heart Failure) c …
Torsemide in the Management of Essential Hypertension.
Bhattacharyya K, Tiwaskar M, Datta A, Chandani AL, Agrawal SK, Abdullakutty J, Badani R, Doshi D, Singh V, Advani P, Varghese K, Pandey AK, Francis F, Sugumaran A. Bhattacharyya K, et al. J Assoc Physicians India. 2024 Sep;72(9S):35-37. doi: 10.59556/japi.72.0676. J Assoc Physicians India. 2024. PMID: 39291572 Review.
Torsemide, a loop diuretic, is increasingly recognized for its role in managing essential hypertension. ...Studies have shown that torsemide is comparably effective to other antihypertensive agents in lowering blood pressure, with the added benefit of potentially im …
Torsemide, a loop diuretic, is increasingly recognized for its role in managing essential hypertension. ...Studies have shown that …
Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis.
Kido K, Shimizu M, Hashiguchi M. Kido K, et al. J Am Pharm Assoc (2003). 2019 May-Jun;59(3):432-438. doi: 10.1016/j.japh.2019.01.014. Epub 2019 Mar 4. J Am Pharm Assoc (2003). 2019. PMID: 30846351 Review.
OBJECTIVES: To compare the efficacy and safety of torsemide versus furosemide in patients with heart failure (HF). DATA SOURCES: Medline, Cochrane Library, Web of Science, and Google Scholar database searches for relevant articles from 1946 to May 2018 were performed with …
OBJECTIVES: To compare the efficacy and safety of torsemide versus furosemide in patients with heart failure (HF). DATA SOURCES: Medl …
Torsemide.
Kanderi T, Vaitla P. Kanderi T, et al. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32644601 Free Books & Documents.
Torsemide is a loop diuretic extensively used in the management of heart failure, renal disease, and cirrhosis. Torsemide acts on electrolyte channels in the renal tubules. Significant adverse events include electrolyte abnormalities, photosensitive reactions, and h …
Torsemide is a loop diuretic extensively used in the management of heart failure, renal disease, and cirrhosis. Torsemide acts …
An evaluation of torsemide in patients with heart failure and renal disease.
Peters AE, Mentz RJ, DeWald TA, Greene SJ. Peters AE, et al. Expert Rev Cardiovasc Ther. 2022 Jan;20(1):5-11. doi: 10.1080/14779072.2022.2022474. Epub 2022 Jan 3. Expert Rev Cardiovasc Ther. 2022. PMID: 34936522 Free PMC article. Review.
While furosemide remains the dominant diuretic utilized in current practice, increasing evidence supports potential advantages of torsemide in heart failure (HF) and/or renal disease. AREAS COVERED: This narrative review covers the evidence for use of torsemide in H …
While furosemide remains the dominant diuretic utilized in current practice, increasing evidence supports potential advantages of torsemi …
Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Miles JA, Hanumanthu BK, Patel K, Chen M, Siegel RM, Kokkinidis DG. Miles JA, et al. J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):379-388. doi: 10.2459/JCM.0000000000000794. J Cardiovasc Med (Hagerstown). 2019. PMID: 30950982
Heart failure patients taking torsemide were more likely to have an improvement in New York Heart Association class compared with those on furosemide (OR 0.73, CI 0.58-0.93, I = 19.6%). CONCLUSION: Torsemide is associated with a reduction in intermediate-term heart …
Heart failure patients taking torsemide were more likely to have an improvement in New York Heart Association class compared with tho …
Torsemide in the Management of Pulmonary Edema.
Vora A, Sharma A, Sivakadaksham, Sundar RH, Mandal SC, Chatterjee N, Agarwal A, Bhatnagar MK, Gupta A, Thaploo R, Francis F, Mohanasundaram S. Vora A, et al. J Assoc Physicians India. 2024 Sep;72(9S):38-39. doi: 10.59556/japi.72.0677. J Assoc Physicians India. 2024. PMID: 39291573 Review.
Pharmacological features of torsemide, such as greater bioavailability, higher absorption rate, and efficacy, make it a better alternative for treating pulmonary edema than the regularly used loop diuretic, furosemide. Torsemide administered intravenously was found …
Pharmacological features of torsemide, such as greater bioavailability, higher absorption rate, and efficacy, make it a better altern …
644 results